24 May 2023 ASA ruling on ASEA LLC A recent ASA ruling features a misleading food supplement ad that combines medicinal claims and exaggerated unsupported... ASA ruling on ASEA LLC
16 May 2023 Self-care Strategy Group joint response to the Primary Care Recovery Plan The Government’s plan for recovering access to primary care is welcome news for patients and the NHS,... Self-care Strategy Group joint response to the Primary Care Recovery Plan
10 May 2023 Primary care recovery plan: PAGB success The Government and NHS England have published a Delivery plan for recovering access to primary care. The plan seeks... Primary care recovery plan: PAGB success
4 May 2023 Empowering people to self-care: a toolkit for Primary Care Networks PAGB has developed a toolkit, in collaboration with leading healthcare and pharmacy organisations, to support Primary Care Networks (PCNs) to... Empowering people to self-care: a toolkit for Primary Care Networks
21 March 2023 DHPC (direct to healthcare professional communication) letter regarding pholcodine Pholcodine-containing medicinal products are no longer available on the UK market Following a review by the Medicines and Healthcare products... MHRA logo
15 March 2023 Spring Budget 2023, PAGB comment Today’s Budget announcement included confirmation that the Medicines and Healthcare products Regulatory Agency (MHRA) will receive £10 million extra funding... Spring Budget 2023, PAGB comment
14 March 2023 MHRA’s precautionary decision on pholcodine-containing medicinal products Following a review by the Medicines and Healthcare products Regulatory Agency (MHRA), the UK regulator has taken the precautionary step... MHRA logo
2 March 2023 ASA rejects ‘vaping to quit smoking’ claims A recent ASA ruling highlighted the risks of making smoking cessation claims for products without a relevant MHRA licence. An... ASA rejects ‘vaping to quit smoking’ claims
27 February 2023 PAGB welcomes “very positive outcome” securing supply of medicines for Northern Ireland and UK PAGB welcomes today’s announcement and the positive outcome of these negotiations. We have always said that it is important that... PAGB welcomes “very positive outcome” securing supply of medicines for Northern Ireland and UK
23 February 2023 PAGB statement on the review of pseudoephedrine Available for over 40 years and with a well-established safety profile, pseudoephedrine is an active ingredient which is used as... PAGB statement on the review of pseudoephedrine
20 February 2023 Mail on Sunday coverage of over-the-counter medicines supply Michelle Riddalls, Chief Executive of PAGB, the consumer healthcare association, which represents the manufacturers of over-the counter-medicines (OTC)... Mail on Sunday coverage of over-the-counter medicines supply
15 February 2023 CAP guidance on environmental claims: ‘carbon neutral’ and ‘net zero’ claims The ASA has published updated guidance on environmental claims in advertising, advising marketers to avoid using unqualified carbon neutral, net... CAP guidance on environmental claims: ‘carbon neutral’ and ‘net zero’ claims
